甲状腺癌的表观遗传修饰研究进展

被引：2

作者：

李暐

陶泽璋

机构：

[1] 武汉大学人民医院耳鼻咽喉头颈外科

来源：

中华实验外科杂志 | 2020年 / 37卷 / 09期

关键词：

甲状腺癌; 表观遗传修饰;

D O I：

暂无

中图分类号：

R736.1 [甲状腺肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

甲状腺癌是一种常见的头颈部恶性肿瘤, 近年来发病率逐年上升。甲状腺癌的分子发病机制有待明确。其表观遗传变化是近年来甲状腺癌发病机制方面研究的热点。为进一步揭示甲状腺癌的发病机制、了解其预后及遗传性控制等。本文对甲状腺癌中发现的主要表观遗传学变化的研究进展、甲状腺癌表观遗传治疗策略等进行综述。

引用

共 29 条

[1]

Long non-coding RNA in stem cell pluripotency and lineage commitment: functions and evolutionary conservation [J].

Fico, Annalisa ;

Fiorenzano, Alessandro ;

Pascale, Emilia ;

Patriarca, Eduardo Jorge ;

Minchiotti, Gabriella .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (08) :1459-1471

[2]

Chromatin remodelling and epigenetic state regulation by non-coding RNAs in the diseased heart.[J].F. De Majo;M. Calore.Non-coding RNA Research.2018, 1

[3]

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk [J].

Chornokur, Ganna ;

Lin, Hui-Yi ;

Tyrer, Jonathan P. ;

Lawrenson, Kate ;

Dennis, Joe ;

Amankwah, Ernest K. ;

Qu, Xiaotao ;

Tsai, Ya-Yu ;

Jim, Heather S. L. ;

Chen, Zhihua ;

Chen, Ann Y. ;

Permuth-Wey, Jennifer ;

Aben, Katja K. H. ;

Anton-Culver, Hoda ;

Antonenkova, Natalia ;

Bruinsma, Fiona ;

Bandera, Elisa V. ;

Bean, Yukie T. ;

Beckmann, Matthias W. ;

Bisogna, Maria ;

Bjorge, Line ;

Bogdanova, Natalia ;

Brinton, Louise A. ;

Brooks-Wilson, Angela ;

Bunker, Clareann H. ;

Butzow, Ralf ;

Campbell, Ian G. ;

Carty, Karen ;

Chang-Claude, Jenny ;

Cook, Linda S. ;

Cramer, Daniel W. ;

Cunningham, Julie M. ;

Cybulski, Cezary ;

Dansonka-Mieszkowska, Agnieszka ;

du Bois, Andreas ;

Despierre, Evelyn ;

Dicks, Ed ;

Doherty, Jennifer A. ;

Dork, Thilo ;

Durst, Matthias ;

Easton, Douglas F. ;

Eccles, Diana M. ;

Edwards, Robert P. ;

Ekici, Arif B. ;

Fasching, Peter A. ;

Fridley, Brooke L. ;

Gao, Yu-Tang ;

Gentry-Maharaj, Aleksandra ;

Giles, Graham G. ;

Glasspool, Rosalind .

PLOS ONE, 2015, 10 (06)

[4]

The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer.[J].Prashant Kumar Singh;Moray J. Campbell.Cancers.2013, 3

[5]

Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry [J].

Berdasco, Maria ;

Esteller, Manel .

DEVELOPMENTAL CELL, 2010, 19 (05) :698-711

[6]

Downregulation of Rap1GAP through Epigenetic Silencing and Loss of Heterozygosity Promotes Invasion and Progression of Thyroid Tumors [J].

Zuo, Hui ;

Gandhi, Manoj ;

Edreira, Martin M. ;

Hochbaum, Daniel ;

Nimgaonkar, Vishwajit L. ;

Zhang, Ping ;

DiPaola, James ;

Evdokimova, Viktoria ;

Altschuler, Daniel L. ;

Nikiforov, Yuri E. .

CANCER RESEARCH, 2010, 70 (04) :1389-1397

[7]

Antineoplastic Chemotherapy Induced QTc Prolongation [J].

Bagnes, Claudia ;

Natalia Panchuk, Patricia ;

Recondo, Gonzalo .

CURRENT DRUG SAFETY, 2010, 5 (01) :93-96

[8]

Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation [J].

Borbone, E. ;

Berlingieri, M. T. ;

De Bellis, F. ;

Nebbioso, A. ;

Chiappetta, G. ;

Mai, A. ;

Altucci, L. ;

Fusco, A. .

ONCOGENE, 2010, 29 (01) :105-116

[9]

DNA hypomethylation in cancer cells [J].

Ehrlich, Melanie .

EPIGENOMICS, 2009, 1 (02) :239-259

[10]

Identification of candidate epigenetic biomarkers for ovarian cancer detection [J].

Huang, Yi-Wen ;

Jansen, Rachel A. ;

Fabbri, Enrica ;

Potter, Dustin ;

Liyanarachchi, Sandya ;

Chan, Michael W. Y. ;

Liu, Joseph C. ;

Crijns, Anne P. G. ;

Brown, Robert ;

Nephew, Kenneth P. ;

Van Der Zee, Ate G. J. ;

Cohn, David E. ;

Yan, Pearlly S. ;

Huang, Tim H. -M. ;

Lin, Huey-Jen L. .

ONCOLOGY REPORTS, 2009, 22 (04) :853-861

← 1 2 3 →